Physician profile
Saif Bella
NPI 1013335595
$1,626.99
in general payments reported to CMS, 2019-2025
14 companies · $975 in 2025
The $975 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $474 · 2020: $179 · 2025: $975.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $819 · Food and Beverage: $156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $819.11 |
| Food and Beverage | $155.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $854.25 | 2025 | Single Use Biliary Balloon Dilator |
| Allergan, INC. | $211.86 | 2019-2020 | |
| Genzyme Corporation | $120.49 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $110.57 | 2019 | |
| Abbvie INC. | $91.27 | 2019-2020 | |
| Intercept Pharmaceuticals, INC. | $49.11 | 2019-2020 | |
| Gilead Sciences, INC. | $34.73 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.78 | 2019-2020 | |
| Janssen Biotech, INC. | $30.38 | 2019-2020 | |
| Pfizer INC. | $26.12 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $19.10 | 2019 | |
| Qol Medical, LLC | $18.19 | 2019 | |
| Alfasigma USA, INC. | $15.92 | 2020 | |
| Ucb, INC. | $14.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saif Bella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.